Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on the Pharmacokinetics of BI 3731579 in Healthy Male Subjects
NCT06861829Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of BI 3731579 (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration-time Curve from 0 to the Last Quantifiable Data Point at 72 hours and Maximum Measured Concentration at 72 hours. Started Mar 2025; status: completed.
02
Drugs
BI 3731579
Beyond the preview
Go deeper on NCT06861829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06861829.